Leiden, Netherlands · Founded 2016 · Acquired/Merged (Operating Subsidiary)
Manufacturer of therapeutic drugs designed to restore blood clotting in patients experiencing bleeding events. VarmX is based in Leiden, Netherlands and was founded in 2016. Its last known valuation is $505 million (Sep 2025). It has raised $103 million.
Last price · $/share
—
Implied valuation
$505.0M
Total raised
$102.5M
Last round
—
Cap table — not yet on record
VarmX's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of VarmX with a free account
·The complete investor list: 13 names
·Watch VarmX: the Monday email on marks, rounds and moves
